Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
作者信息
Berns Kenneth I, Byrne Barry J, Flotte Terence R, Gao Guangping, Hauswirth William W, Herzog Roland W, Muzyczka Nicholas, VandenDriessche Thierry, Xiao Xiao, Zolotukhin Sergei, Srivastava Arun
机构信息
1 Powell Gene Therapy Center, University of Florida College of Medicine , Gainesville, Florida.
2 Genetics Institute, University of Florida College of Medicine , Gainesville, Florida.
出版信息
Hum Gene Ther. 2015 Dec;26(12):779-81. doi: 10.1089/hum.2015.29014.kib.
Abstract
摘要
相似文献
1
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
Hum Gene Ther. 2015 Dec;26(12):779-81. doi: 10.1089/hum.2015.29014.kib.
2
Adeno-associated virus finds its disease.
Nat Genet. 2015 Oct;47(10):1104-5. doi: 10.1038/ng.3407.
3
AAV2 and Hepatocellular Carcinoma.
Hum Gene Ther. 2016 Mar;27(3):211-3. doi: 10.1089/hum.2016.002.
4
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.
5
AAV vector integration sites in mouse hepatocellular carcinoma.
Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.
6
AAV Infection: Protection from Cancer.
Hum Gene Ther. 2017 Apr;28(4):323-327. doi: 10.1089/hum.2016.147. Epub 2016 Nov 10.
7
Retrotransposons: a new and credible source of inherited and somatically acquired hepatocellular carcinoma mutations.
J Hepatol. 2013 Sep;59(3):616-7. doi: 10.1016/j.jhep.2013.05.001. Epub 2013 May 9.
8
[Construction of recombinant adeno-associated virus vectors carrying double gene of antisense multidrug resistance-associated protein and antisense multidrug resistance].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Nov;36(6):765-9.
9
rAAV-mediated tumorigenesis: still unresolved after an AAV assault.
Mol Ther. 2012 Nov;20(11):2014-7. doi: 10.1038/mt.2012.220.
10
Jump-starting cancer gene discovery.
Nat Biotechnol. 2009 Mar;27(3):251-2. doi: 10.1038/nbt0309-251.
引用本文的文献
1
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.
Curr Issues Mol Biol. 2024 Aug 2;46(8):8464-8498. doi: 10.3390/cimb46080499.
2
Pathogenicity and virulence of human adenovirus F41: Possible links to severe hepatitis in children.
Virulence. 2023 Dec;14(1):2242544. doi: 10.1080/21505594.2023.2242544.
3
Liver directed adeno-associated viral vectors to treat metabolic disease.
J Inherit Metab Dis. 2024 Jan;47(1):22-40. doi: 10.1002/jimd.12637. Epub 2023 Jun 5.
4
Cell and gene therapy for kidney disease.
Nat Rev Nephrol. 2023 Jul;19(7):451-462. doi: 10.1038/s41581-023-00702-3. Epub 2023 Mar 27.
5
Genomic Designs of rAAVs Contribute to Pathological Changes in the Livers and Spleens of Mice.
Adv Cell Gene Ther. 2022;2022. doi: 10.1155/2022/6807904. Epub 2022 Mar 20.
6
Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response.
Nat Commun. 2022 Nov 25;13(1):7275. doi: 10.1038/s41467-022-34898-y.
7
Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies.
Hum Gene Ther. 2022 Nov;33(21-22):1126-1141. doi: 10.1089/hum.2022.090. Epub 2022 Sep 14.
8
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
Mol Ther. 2022 Aug 3;30(8):2646-2663. doi: 10.1016/j.ymthe.2022.06.004. Epub 2022 Jun 10.
9
Cryo-electron Microscopy of Adeno-associated Virus.
Chem Rev. 2022 Sep 14;122(17):14018-14054. doi: 10.1021/acs.chemrev.1c00936. Epub 2022 May 16.
10
Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis.
BMC Genomics. 2021 Nov 11;22(1):814. doi: 10.1186/s12864-021-08098-9.
本文引用的文献
1
Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
Mol Ther. 2015 Dec;23(12):1867-76. doi: 10.1038/mt.2015.174. Epub 2015 Sep 25.
2
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nat Genet. 2015 Oct;47(10):1187-93. doi: 10.1038/ng.3389. Epub 2015 Aug 24.
3
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
Hepatology. 2015 Oct;62(4):1190-200. doi: 10.1002/hep.27969.
4
Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspective.
Hum Gene Ther. 2015 May;26(5):257-65. doi: 10.1089/hum.2015.025. Epub 2015 Apr 20.
5
Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs.
Hum Gene Ther Clin Dev. 2015 Mar;26(1):5-14. doi: 10.1089/humc.2014.153. Epub 2015 Feb 12.
6
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
J Clin Invest. 2015 Feb;125(2):870-80. doi: 10.1172/JCI79213. Epub 2015 Jan 20.
7
Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.
Mol Ther. 2012 Nov;20(11):2098-110. doi: 10.1038/mt.2012.197. Epub 2012 Sep 18.
8
Assessing the potential for AAV vector genotoxicity in a murine model.
Blood. 2011 Mar 24;117(12):3311-9. doi: 10.1182/blood-2010-08-302729. Epub 2010 Nov 24.
9
AAV vector integration sites in mouse hepatocellular carcinoma.
Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.
10
Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver.
Mol Ther. 2006 Jul;14(1):34-44. doi: 10.1016/j.ymthe.2006.03.008. Epub 2006 May 6.
Zotero 插件